Strongbridge Bio Ord
(SBBP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 31,851 | -52,205 | -31,646 | -28,723 | -113,483 |
| Depreciation Amortization | 7,233 | 5,545 | 3,651 | 1,772 | 5,032 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 1,958 |
| Accounts receivable | -42 | -958 | -792 | -432 | -1,584 |
| Accounts payable and accrued liabilities | -63 | 1,980 | 1,164 | 921 | 158 |
| Other Working Capital | -7,331 | 956 | -1,919 | -4,036 | 126 |
| Other Operating Activity | -116,224 | -7,182 | -3,006 | 12,479 | 62,457 |
| Operating Cash Flow | $-84,576 | $-51,864 | $-32,548 | $-18,019 | $-45,336 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -326 | -310 | -310 | N/A | N/A |
| Net Acquisitions | 134,656 | -24,655 | -24,655 | -24,655 | -7,500 |
| Investing Cash Flow | $134,330 | $-24,965 | $-24,965 | $-24,655 | $-7,500 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 44,930 | 44,930 | 44,930 | 44,930 | 39,987 |
| Debt Repayment | -85,000 | -500 | N/A | N/A | -22,261 |
| Common Stock Issued | 65,759 | 42,713 | 41,528 | 33,567 | 27,083 |
| Other Financing Activity | -10,463 | -441 | -941 | -928 | -1,300 |
| Financing Cash Flow | $15,226 | $86,702 | $85,517 | $77,569 | $43,509 |
| Beginning Cash Position | 57,510 | 57,510 | 57,510 | 57,510 | 66,837 |
| End Cash Position | 122,490 | 67,383 | 85,514 | 92,405 | 57,510 |
| Net Cash Flow | $64,980 | $9,873 | $28,004 | $34,895 | $-9,327 |
| Free Cash Flow | |||||
| Operating Cash Flow | -84,576 | -51,864 | -32,548 | -18,019 | -45,336 |
| Capital Expenditure | -326 | -310 | -310 | N/A | N/A |
| Free Cash Flow | -84,902 | -52,174 | -32,858 | -18,019 | -45,336 |